Second World Parkinson Congress
Second World Parkinson Congress
批准号:
7917943
负责人:
STANLEY FAHN
金额:
$13.5万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-04-15 至 2011-04-14
关键词:
AddressAdvocacyAreaAttentionAwarenessCaregiversCaringClinical TrialsCollaborationsCommittee MembersCommunitiesCongressesCountryDevelopmentDiseaseEducational workshopFaceFosteringGovernmentHealth ProfessionalInternationalLearningLifeNursesParkinson DiseasePatientsPhysiciansQuality of lifeResearchResearch PersonnelScienceScientistScotlandSolutionsStagingTimeWorkcareerclinical caredesignimprovedinnovationinterestmeetingsmembernovel strategiespostersprofession allied to medicineprogramspublic health relevancewillingness
中文摘要
描述(由申请人提供):第二届世界帕金森大会(WPC 2010)的目的是解决全球对话的需求,以解决帕金森病的多方面问题,并提出解决方案,包括新的研究方法和更好的帕金森病患者治疗方案。WPC 2010将于2010年9月28日至10月1日在苏格兰格拉斯哥举行,这是帕金森病(PD)领域唯一的国际会议,旨在将整个PD社区聚集在一起,举行高水平的科学和非专业会议。参加会议的代表将代表来自50多个国家的神经科学家、医生、PD患者、护理人员、护士、联合卫生专业人员、政府代表和倡导社区的其他成员。这个为期四天的项目重点介绍了目前正在进行的工作,以推进帕金森病的科学发展,并改善对帕金森病患者的护理。让美国的研究人员了解世界其他地区取得的科学进步,将有助于他们探索新的想法,建立他们在其他情况下可能无法建立的合作。PD社区的广泛支持和参与将使WPC能够为社区的交叉授粉创造一个场所,在卫生专业人员、研究人员和患者之间建立合作和互动,否则他们可能不会见面。这些互动将刺激创新研究,确定未满足需求的解决方案,并推进PD患者的治疗。委员会共有75名成员,其中38人(包括PD患者)设计了一个精心设计的项目,以提高科学家和临床医生对PD独特方面的认识,加深他们对PD研究的承诺,并可能促进对PD较少研究方面的研究。与此同时,该计划有望使患者和护理人员接触到研究,并在理想情况下增加参与临床试验的意愿和兴趣,这是当今研究人员面临的主要挑战。从PD社区的各个领域邀请演讲者,以各种方式举办会议,以最大限度地发挥学习潜力和对话,包括多达1000名代表的全体会议,200 - 550名代表的平行会议以及约100名代表的更亲密的讲习班。上午全体会议围绕一个主题进行设计,并作为所有与会者每天开始的会议场所,为后续会议奠定基础,并激发当天晚些时候的进一步讨论。平行会议和研讨会将涵盖1)科学的新发展,2)临床护理的概念,以及3)与生活质量有关的问题;提供为期一天的讨论,以保持科学家,临床医生和患者的不同兴趣。大会每天都会有科学和帕金森生活的海报,这些海报由项目委员会审查和接受。这个广泛的海报会议旨在最大限度地发挥研究人员,临床医生,患者和职业之间的互动。每天最优秀的三幅海报将在每天开始的“热点话题”环节中展示。将举办海报巡展,密切关注该领域最有前途的工作,并增加PD社区利益相关者之间的对话和合作。
英文摘要
DESCRIPTION (provided by applicant): The purpose of the 2nd World Parkinson Congress (WPC 2010) is to address a need for worldwide dialogue to address the multifaceted problems of PD and propose solutions including new approaches to research and better treatment options for people with PD. The WPC 2010, to be held from September 28 - October 1, 2010 in Glasgow, Scotland is the only international meeting in the field of Parkinson's disease (PD) responding to a need to bring the whole PD community together for high-level scientific and lay sessions. Delegates at the meeting will represent neuroscientists, physicians, people with PD, caregivers, nurses, allied health professionals, government representatives, and other members of the advocacy community from more than 50 countries. The four-day program highlights current work being done to advance the science of PD and to improve care for people living with the disease. Exposing researchers from the US to the scientific advancements made in other parts of the world will help them explore new ideas and build collaborations they might otherwise not build. Broad support and involvement from the PD community will allow the WPC to create a venue for cross pollination of the community to build collaborations and interactions between health professionals, researchers, and patients who might not otherwise meet. These interactions will spur innovative research, identify solutions to unmet needs and advance therapies for people with PD. Thirty-eight, of a total of 75 committee members, including people living with PD, designed an elaborate program to raise awareness among scientists and clinicians about unique aspects of PD to deepen their commitment to PD research and possibly foster research on less studied aspects of PD. At the same time, the program is expected to expose patients and caregivers to research and ideally increase willingness and interest in participating in clinical trials, which is a major challenge for researchers today. Speakers are being invited from all areas of the PD community with sessions formatted in a variety of ways to maximize the learning potential and dialogue, including plenaries with up to 1,000 delegates, parallel sessions with 200 - 550 delegates and more intimate workshops, of around 100 delegates. The morning plenaries are designed around a theme and used as a meeting ground for all attendees to start each day with a topic that sets the stage for following sessions and stimulates further discussion later in the day. Parallel sessions and workshops will cover 1) new developments in science, 2) concepts on clinical care, and 3) issues related to quality of life; providing day-long discussions to hold the diverse interest of scientists, clinicians, and patients. There will be both Scientific and Living with Parkinson's posters each day of the Congress that were reviewed and accepted by the Program Committee. This broad range of posters sessions is designed to maximize interaction among researchers, clinicians, patients, and careers. The three most outstanding posters each day will be presented in a 'Hot Topics' session at the beginning of each day. Poster tours will be held paying keen attention to the most promising work in the field and to increase dialogue and collaboration between the stakeholders in the PD community.
PUBLIC HEALTH RELEVANCE: The purpose of the 2nd World Parkinson Congress is to create a worldwide dialogue to discuss the multifaceted problems of PD, propose solutions including new approaches to research, build innovative collaborations, and create better treatment options for people with PD. It is the only meeting in the field of Parkinson's disease (PD) that addresses a need to bring the whole PD community together for high-level scientific sessions and discussions on current work being done to advance science, improve care for people with PD and help sensitize researchers to the needs of people with PD and conversely help patients understand the challenges researchers and health professionals face when studying PD. Uniquely, the delegates at the meeting represent neuroscientists, physicians, people with PD, caregivers, nurses, allied health professionals, government representatives, and other members of the advocacy community.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The 3rd World Parkinson Congress is a four-day scientific conference designed to
-
批准号:8529290
-
项目类别:
-
资助金额:$7.45万
-
财政年份:2013
-
负责人:STANLEY FAHN
-
依托单位:
World Parkinson Congress 2006
-
批准号:7058484
-
项目类别:
-
资助金额:$17.5万
-
财政年份:2005
-
负责人:STANLEY FAHN
-
依托单位:
FOURTH INTERNATIONAL DYSTONIA SYMPOSIUM
-
批准号:6361939
-
项目类别:
-
资助金额:$3.0万
-
财政年份:2001
-
负责人:STANLEY FAHN
-
依托单位:
FETAL TISSUE TRANSPLANT STUDY
-
批准号:6567769
-
项目类别:
-
资助金额:$19.29万
-
财政年份:2001
-
负责人:STANLEY FAHN
-
依托单位:
INTL SYMPOSIUM ON MYOCLONUS AND PAROXYSMAL DISORDERS
-
批准号:6166545
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2000
-
负责人:STANLEY FAHN
-
依托单位:
FETAL TISSUE TRANSPLANT STUDY
-
批准号:6468508
-
项目类别:
-
资助金额:$19.29万
-
财政年份:2000
-
负责人:STANLEY FAHN
-
依托单位:
PARKINSON'S DISEASE RESEARCH CENTER AT COLUMBIA
-
批准号:6188160
-
项目类别:
-
资助金额:$157.36万
-
财政年份:1999
-
负责人:STANLEY FAHN
-
依托单位:
PARKINSONS DISEASE RESEARCH CENTER
-
批准号:6076350
-
项目类别:
-
资助金额:$158.04万
-
财政年份:1999
-
负责人:STANLEY FAHN
-
依托单位:
PARKINSONS DISEASE RESEARCH CENTER
-
批准号:6266039
-
项目类别:
-
资助金额:$0.34万
-
财政年份:1999
-
负责人:STANLEY FAHN
-
依托单位:
PARKINSON'S DISEASE RESEARCH CENTER AT COLUMBIA
-
批准号:6529371
-
项目类别:
-
资助金额:$163.52万
-
财政年份:1999
-
负责人:STANLEY FAHN
-
依托单位:
PARKINSON'S DISEASE RESEARCH CENTER AT COLUMBIA
-
批准号:6394074
-
项目类别:
-
资助金额:$160.13万
-
财政年份:1999
-
负责人:STANLEY FAHN
-
依托单位:
Earlier vs. Later Levodopa in Parkinson's Disease
-
批准号:6500592
-
项目类别:
-
资助金额:$6.4万
-
财政年份:1998
-
负责人:STANLEY FAHN
-
依托单位:
FETAL TISSUE TRANSPLANT STUDY
-
批准号:6220008
-
项目类别:
-
资助金额:$0.04万
-
财政年份:1998
-
负责人:STANLEY FAHN
-
依托单位:
EARLIER VS LATER L DOPA IN PARKINSONS DISEASE
-
批准号:6139523
-
项目类别:
-
资助金额:$179.91万
-
财政年份:1998
-
负责人:STANLEY FAHN
-
依托单位:
Earlier vs. Later Levodopa in Parkinson's Disease
-
批准号:6384099
-
项目类别:
-
资助金额:$36.57万
-
财政年份:1998
-
负责人:STANLEY FAHN
-
依托单位:
TISSUE RESOURCE FACILITY
-
批准号:6117619
-
项目类别:
-
资助金额:$2.21万
-
财政年份:1998
-
负责人:STANLEY FAHN
-
依托单位:
FETAL TISSUE TRANSPLANT STUDY
-
批准号:6117634
-
项目类别:
-
资助金额:$2.21万
-
财政年份:1998
-
负责人:STANLEY FAHN
-
依托单位:
Earlier vs. Later Levodopa in Parkinson's Disease
-
批准号:6529181
-
项目类别:
-
资助金额:$78.21万
-
财政年份:1998
-
负责人:STANLEY FAHN
-
依托单位:
EARLIER VS LATER L DOPA IN PARKINSONS DISEASE
-
批准号:2038124
-
项目类别:
-
资助金额:$177.47万
-
财政年份:1998
-
负责人:STANLEY FAHN
-
依托单位:
EARLIER VS LATER L DOPA IN PARKINSONS DISEASE
-
批准号:2858182
-
项目类别:
-
资助金额:$191.63万
-
财政年份:1998
-
负责人:STANLEY FAHN
-
依托单位:
海外基金